The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC)held its seventh meeting from 4 to 7 February 2013.
For an overview of all information available following the meeting of the PRAC, please see the table below.
The Agency publishes a new page following the PRAC meeting each month. The minutes of each PRAC meeting will be published during the week following the subsequent PRAC.
View the agenda and other sources here.
Related LinksSAE Rates in Clinical Trials
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.